Literature DB >> 7720157

Monitoring complication due to a pulsatile femoral vein from tricuspid regurgitation.

I Gilron1, S Magder.   

Abstract

This clinical report illustrates a monitoring complication due to a pulsatile femoral vein from tricuspid regurgitation. In this case, the femoral vein of a patient was inadvertently cannulated and exhibited a pulsatile tracing which was mistaken for an arterial pressure tracing. This led to the initial inappropriate use of vasopressors which actually augmented the pulsatility and delayed detection of the error. Although this may be a rare occurrence, the clinician should be aware of its possibility when using invasive monitoring in a patient with tricuspid regurgitation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7720157     DOI: 10.1007/BF03028267

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  5 in total

1.  Pulsating varicose veins in functional tricuspid insufficiency. Case report and venous pressure tracing.

Authors:  P W BRICKNER; W T SCUDDER; M WEINRIB
Journal:  Circulation       Date:  1962-01       Impact factor: 29.690

2.  Pulsatile varicose veins--a sign of tricuspid regurgitation.

Authors:  W H Chow; K L Cheung
Journal:  Br J Clin Pract       Date:  1990-12

3.  Pulsatile varicose veins associated with tricuspid regurgitation.

Authors:  G W Hollins; J Engeset
Journal:  Br J Surg       Date:  1989-02       Impact factor: 6.939

4.  Pulsatile varicose veins.

Authors:  R L Blackett; G E Heard
Journal:  Br J Surg       Date:  1988-09       Impact factor: 6.939

5.  Unilateral pulsatile varicose veins from tricuspid regurgitation.

Authors:  H O Klein; D Shachor; N Schneider; D David
Journal:  Am J Cardiol       Date:  1993-03-01       Impact factor: 2.778

  5 in total
  1 in total

Review 1.  Normalizing physiological variables in acute illness: five reasons for caution.

Authors:  Brian P Kavanagh; L Joanne Meyer
Journal:  Intensive Care Med       Date:  2005-07-26       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.